Detalhe da pesquisa
1.
Monitoring of plasma concentrations of dabrafenib and trametinib in advanced BRAFV600mut melanoma patients.
Ann Dermatol Venereol
; 149(1): 32-38, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183171
2.
Relevance of body mass index as a predictor of systemic therapy outcomes in metastatic melanoma: analysis of the MelBase French cohort dataâ.
Ann Oncol
; 32(4): 542-551, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33385520
3.
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomes.
Br J Dermatol
; 184(6): 1113-1122, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33236347
4.
Which adjuvant treatment for patients with BRAFV600-mutant cutaneous melanoma?
Ann Dermatol Venereol
; 148(3): 145-155, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579557
5.
The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force.
J Eur Acad Dermatol Venereol
; 34(10): 2183-2197, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32840022
6.
Impact of the French COVID-19 pandemic lockdown on newly diagnosed melanoma delay and severity.
J Eur Acad Dermatol Venereol
; 36(3): e164-e166, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753221
7.
Formalin-fixed tissue Mohs surgery (slow Mohs) for trichoblastic carcinoma.
J Eur Acad Dermatol Venereol
; 36(10): e827-e828, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686623
8.
First-in-human phase I study of the DNA-repair inhibitor DT01 in combination with radiotherapy in patients with skin metastases from melanoma.
Br J Cancer
; 114(11): 1199-205, 2016 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27140316
9.
Prospective assessment of a gene signature potentially predictive of clinical benefit in metastatic melanoma patients following MAGE-A3 immunotherapeutic (PREDICT).
Ann Oncol
; 27(10): 1947-53, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27502712
10.
Second primary cutaneous melanoma in patients with advanced melanoma treated with anti-programmed-death-receptor-1 monoclonal antibodies.
Br J Dermatol
; 184(4): 746-748, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33098566
11.
Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance.
Ann Oncol
; 26(7): 1470-5, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25899783
12.
Frequency and prognostic value of cutaneous molecular residual disease in mycosis fungoides: a prospective multicentre trial of the Cutaneous Lymphoma French Study Group.
Br J Dermatol
; 173(4): 1015-23, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149621
13.
Sun exposure profile in the French population. Results of the EDIFICE Melanoma survey.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 6-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639926
14.
EDIFICE Melanoma survey: knowledge and attitudes on melanoma prevention and diagnosis.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 11-5, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639927
15.
Comparison of sun protection modalities in parents and children.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 16-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639928
16.
Evolution of sun-protection measures for children.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 20-2, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639929
17.
Personal vs. intrinsic melanoma risk awareness: results of the EDIFICE Melanoma survey.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 31-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639931
18.
Prevalence of sunbed use, and characteristics and knowledge of sunbed users: results from the French population-based Edifice Melanoma survey.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 23-30, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639930
19.
Melanoma risk-takers: fathers and sons.
J Eur Acad Dermatol Venereol
; 29 Suppl 2: 35-8, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25639932
20.
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery]. / Métastases en transit du mélanome : efficacité de l'imiquimod topique combiné au laser CO2 ou à l'électrocoagulation.
Ann Dermatol Venereol
; 141(2): 106-10, 2014 Feb.
Artigo
em Francês
| MEDLINE | ID: mdl-24507204